London-based biotech startup Baseimmune is using big data and a design algorithm to help develop future-proofed vaccines.
The Imperial College spin-off recently announced a €4.1 million ($4.8m) raise to develop vaccines against existing and emerging human and animal health threats including COVID-19, malaria and African swine fever.
Baseimmune’s technology harnesses pathogen and epidemiological big data combined with biological expertise to devise a robust method for antigen discovery, which is one of the major roadblocks in vaccine development.
WHY IT MATTERS
Most vaccine antigens are based on a single pathogen component, such as the spike protein of the COVID SARS-CoV-2 coronavirus, which limits their effectiveness and ability to cope with new variants.
Baseimmune’s vaccine…
…
From: {source site name} – Read more
